New Product Briefs
This article was originally published in The Gray Sheet
Product announcements from St. Jude, Medtronic, BD, Masimo and Fujifilm Medical.
You may also be interested in...
The software builds on the company’s MultiPoint pacing technology for optimizing cardiac resynchronization therapy for heart failure patients.
In this week's podcast edition of Five Must-Know Things: GSK’s R&D head departs; Bayer’s pharma R&D chief prioritizes assets; new US launches in atopic dermatitis; is Abivax an M&A target; and China’s gene therapy developers rush to the clinic.
Novo Nordisk's oral semaglutide debuts in India at a monthly cost of about $135 and promises to transform diabetes management in the country. Will it impact the SGLT-2 inhibitor class and potentially cannibalize injectable GLP-1 receptor agonists?